Gold Price Analysis: XAU/USD eyes $1,860 after Moderna's vaccine news – Confluence Detector
|Gold has been losing ground after Moderna reported that its COVID-19 vaccine is 94.5% efficient. The Massachusetts-based pharmaceutical company follows in the footsteps of Pfizer and BioNTech, which announced a 90% efficacy last week. Additional efforts by AstraZeneca, Johnson&Johnson, and CureVac are eyed.
The growing chances of a quick exit from the covid crisis imply that less fiscal and monetary stimulus would be needed. In turn, the precious metal would have fewer funds to rise on.
How is XAU/USD positioned after the second coronavirus vaccine report?
The Technical Confluences Indicator is showing that gold is facing fierce resistance at $1,877, which is the convergence of the Bollinger Band 1h-Lower, the Fibonacci 23.6% one-month, and the Fibonacci 23.6% one-week.
Further above, another hurdle awaits at around $1,889, which is where several lines hit the price. These include the Simple Moving Average 50-15m, the Fibonacci 23.6% one-day, and the Fibonacci 38.2% one-month.
Looking down, weak support awaits at $1,865, which is a confluence area including the Pivot Point one-day Support 2 and the previous 4h-low.
It is followed by a critical cushion at $1,860, which is where the Fibonacci 61.8% one-day meets the previous month's low.
All in all, resistance is stronger than support, pointing to further downside.
Key XAU/USD resistances and supports
Confluence Detector
The Confluence Detector finds exciting opportunities using Technical Confluences. The TC is a tool to locate and point out those price levels where there is a congestion of indicators, moving averages, Fibonacci levels, Pivot Points, etc. Knowing where these congestion points are located is very useful for the trader, and can be used as a basis for different strategies.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.